SAURABH SAHA
CIK 1861926 · Chief Executive Officer · last filed 2026-05-15
SAURABH SAHA is a Chief Executive Officer who has filed 67 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for CLVT, was dated May 15, 2026. Across all open-market trades the lifetime net is −$14.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $325.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$325.8K
2
67
-$14.63M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLVT | Director | 170,601 | $1.91 | $325.8K | $135.0K | 6 | 2026-05-15 |
| Centessa Pharmaceuticals plc (CNTA) Delisted | Chief Executive Officer | 259,017 | $40.50 | $10.49M | -$14.76M | 34 | 2025-07-21 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | CLVT | Mixed | +54,086 | -$20.0K | EDGAR |
| 2026-01-21 | — | Notice (144) | −2,300,000 | -$52.60M | EDGAR |
| 2026-01-02 | — | Notice (144) | −2,500,000 | -$60.75M | EDGAR |
| 2025-07-21 | — | Notice (144) | −55,000 | -$879.5K | EDGAR |
| 2025-07-21 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | — | -$663.9K | EDGAR |
| 2025-06-20 | — | Notice (144) | −55,000 | -$707.6K | EDGAR |
| 2025-06-20 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | — | -$483.1K | EDGAR |
| 2025-05-20 | — | Notice (144) | −55,000 | -$700.7K | EDGAR |
| 2025-05-20 | Centessa Pharmaceuticals plc (CNTA) Delisted | Mixed | — | -$487.4K | EDGAR |
| 2025-05-08 | CLVT | Mixed | +34,499 | -$20.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.